中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
28期
151-152,155
,共3页
急性脑出血%醒脑静注射液%临床效果
急性腦齣血%醒腦靜註射液%臨床效果
급성뇌출혈%성뇌정주사액%림상효과
Acute cerebral hemorrhage%XNJI%Clinical effect
目的 分析和研究采用醒脑静注射液对急性脑出血患者进行临床治疗的效果情况. 方法 随机择取 2009年6月—2015年6月以来, 在该院进行诊治的200例急性脑出血患者. 将他们根据入院就诊时间平均划分成对照组和观察组两组(每组患者100例),分别采用常规疗法和醒脑静注射液进行临床治疗,将两组患者的临床治疗情况和效果进行对比分析.结果 观察组患者临床治疗后的神经功能缺损评分(8.1±3.2)明显低于对照组患者(12.3±4.0),而观察组的临床总有效率(92.0%)与对照组患者(81.0%)相比明显较高,两组比较差异有统计学意义(P<0.05). 观察组患者的不良反应率(1.0%)略高于对照组患者(0),但比较结果差异无统计学意义(P>0.05).结论 采用醒脑静注射液对急性脑出血患者进行临床治疗,其疗效显著,患者神经功能恢复理想,不良反应少,因此,它是一种有效、安全、理想、科学的临床治疗方法.
目的 分析和研究採用醒腦靜註射液對急性腦齣血患者進行臨床治療的效果情況. 方法 隨機擇取 2009年6月—2015年6月以來, 在該院進行診治的200例急性腦齣血患者. 將他們根據入院就診時間平均劃分成對照組和觀察組兩組(每組患者100例),分彆採用常規療法和醒腦靜註射液進行臨床治療,將兩組患者的臨床治療情況和效果進行對比分析.結果 觀察組患者臨床治療後的神經功能缺損評分(8.1±3.2)明顯低于對照組患者(12.3±4.0),而觀察組的臨床總有效率(92.0%)與對照組患者(81.0%)相比明顯較高,兩組比較差異有統計學意義(P<0.05). 觀察組患者的不良反應率(1.0%)略高于對照組患者(0),但比較結果差異無統計學意義(P>0.05).結論 採用醒腦靜註射液對急性腦齣血患者進行臨床治療,其療效顯著,患者神經功能恢複理想,不良反應少,因此,它是一種有效、安全、理想、科學的臨床治療方法.
목적 분석화연구채용성뇌정주사액대급성뇌출혈환자진행림상치료적효과정황. 방법 수궤택취 2009년6월—2015년6월이래, 재해원진행진치적200례급성뇌출혈환자. 장타문근거입원취진시간평균화분성대조조화관찰조량조(매조환자100례),분별채용상규요법화성뇌정주사액진행림상치료,장량조환자적림상치료정황화효과진행대비분석.결과 관찰조환자림상치료후적신경공능결손평분(8.1±3.2)명현저우대조조환자(12.3±4.0),이관찰조적림상총유효솔(92.0%)여대조조환자(81.0%)상비명현교고,량조비교차이유통계학의의(P<0.05). 관찰조환자적불량반응솔(1.0%)략고우대조조환자(0),단비교결과차이무통계학의의(P>0.05).결론 채용성뇌정주사액대급성뇌출혈환자진행림상치료,기료효현저,환자신경공능회복이상,불량반응소,인차,타시일충유효、안전、이상、과학적림상치료방법.
Objective To analyze and study the effect of the case XNJI acute cerebral hemorrhage for clinical treatment. Methods Choose to take in June 2009 - June 2015, our department in the diagnosis and treatment of 200 cases of acute cerebral hemor-rhage. Divided according to their average treatment time of admission into the control group and the observation group two (n=100 cases of patients each) were used to conventional therapy and XNJI clinical treatment, and compared two groups of patients and statistical analysis The clinical effectiveness of treatment. Results The statistical comparison showed that patients in the observa-tion group after treatment neurological deficit scores(8.1±3.2) was significantly lower than the control group of patients (12.3±4.0), total clinical efficiency (92.0%) was significantly higher in patients (81.0%), the two groups significant differences are statistically significant (P<0.05). Adverse reaction rates (1.0%) is slightly higher than the observation group were patients (0), but the results were not significant, there was no significant (P>0.05). Conclusion XNJI acute cerebral hemorrhage clinical treatment, the effect is significant, recovery of neurological function in patients with ideal, fewer adverse reactions, therefore, it is an effective and safe, ideal, clinical scientific method.
